Business Segments Nipro Corporation

Stocks

Delayed Japan Exchange 10:30:00 13/08/2026 +04			5-day change	1st Jan Change
1,585.00 ^JPY	-1.58%		-1.31%	+7.31%

07-30	Nipro Corporation Receives Fda 510(K) Clearance for Elisio-Hx Dialyzer and Introduces Hds to the United States	CI
07-29	Vat Holding AG agreed to acquire 100% stake in Atonarp Inc. from Nipro Corporation for CHF 110 million.	CI

Breakdown by Business Segment (JPY)

Fiscal Period: March	2022	2023	2024	2025	2026
Medical Consumables
Medical Related	380B	426B	459B	512B	531B
Total Assets	542B	619B	664B	712B	779B
CAPEX	-56.82B	-49.1B	-48.68B	-41.49B	-35.6B
D&A	22.67B	24.76B	31.78B	37.75B	38.75B
Operating Income	39.24B	38.6B	42.32B	46.63B	52.34B
Pharmaceutical related	94.98B	95.23B	130B	143B	142B
Total Assets	204B	222B	243B	266B	277B
CAPEX	-23.36B	-23.46B	-31.87B	-19.8B	-25.88B
D&A	13.43B	13.39B	15.04B	15.32B	14.53B
Operating Income	9.83B	5.62B	4.43B	10.62B	12.1B
Pharma Packaging	52.49B	57.72B	64.29B	66.1B	62.01B
Total Assets	83.26B	97.15B	111B	113B	116B
CAPEX	-9.32B	-15.69B	-14.54B	-11.72B	-6.41B
D&A	5.09B	5.63B	6.54B	7.46B	5.51B
Operating Income	2.89B	2.74B	2.45B	-272M	-1.58B
Real Estate Operators And Lessors
Others	2.66B	4.44B	4.96B	7.29B	7.1B
Total Assets	158B	202B	234B	250B	274B
CAPEX	-281M	-365M	-739M	-1.01B	-362M
D&A	299M	339M	407M	525M	674M
Operating Income	101M	257M	80M	245M	940M
Unallocated Adjustment	-35.18B	-38.26B	-71.4B	-83.78B	-81.2B
Total Assets	-56.98B	-112B	-142B	-171B	-232B
CAPEX	-7.01B	-14.02B	-7.79B	-7.47B	-2.84B
D&A	4.68B	4.63B	5.1B	4.59B	4.28B
Operating Income	-28.18B	-29.48B	-26.95B	-30.63B	-26.16B

Geographical breakdown of sales (JPY)

Fiscal Period: March	2022	2023	2024	2025	2026
Japan	280B	290B	305B	314B	309B
Total Assets	250B	276B	304B	309B	299B
Asia	76.08B	88.64B	96.96B	107B	101B
Total Assets	76.04B	87.64B	92.92B	101B	98.8B
Europe	60.38B	68.29B	77.2B	92.63B	50.34B
Total Assets	29.29B	39.42B	50.01B	50.34B	56.68B
U.S.A	78.24B	98.09B	108B	130B	42.82B
Total Assets	22.29B	29.74B	34.12B	42.82B	47.79B